Absence of A673T amyloid-β precursor protein variant in alzheimer's disease and other neurological diseases

Neurobiology of Aging

Volumn 34, Issue 10, 2013, Pages 2441.e7-2441.e8

  Ting, Simon Kang Seng ^a,b   Chong, Mei Sian ^d   Kandiah, Nagaendran ^b,d   Hameed, Shahul ^a,b   Tan, Louis ^b,d   Au, Wing Lok ^b,d   Prakash, Kumar M ^a,b   Pavanni, Ratnagopal ^a,b   Lee, Tih Shih ^g   Foo, Jia Nee ^c   Bei, Jin Xin ^c,e   Yu, Xue Qing ^f   Liu, Jian Jun ^c,h   Zhao, Yi ^a   Lee, Wei Ling ^b,d   Tan, Eng King ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g DUKE NUS MEDICAL SCHOOL   (Singapore)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

A673T; Amyloid beta precursor protein; Dementia

Indexed keywords

ALANINE; AMYLOID PRECURSOR PROTEIN; PROTEIN VARIANT; THREONINE;

AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMYLOID PRECURSOR PROTEIN GENE; ARTICLE; ASIAN; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NEUROPROTECTION; POPULATION GENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879881335     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.04.012     Document Type: Article

References (6)

1. Bateman R.J., Aisen P.S., De Strooper B., Fox N.C., Lemere C.A., Ringman J.M., Salloway S., Sperling R.A., Windisch M., Xiong C. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther. 2011, 3:1-13.
2. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992, 360:672-674.
3. Cruchaga C., Haller G., Chakraverty S., Mayo K., Vallania F.L., Mitra R.D., Faber K., Williamson J., Bird T., Diaz-Arrastia R., Foroud T.M., Boeve B.F., Graff-Radford N.R., St Jean P., Lawson M., Ehm M.G., Mayeux R., Goate A.M. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 2012, 7:e31039. NIA-LOAD/NCRAD Family Study Consortium.
4. Jonsson T., Atwal J.K., Steinberg S., Snaedal J., Jonsson P.V., Bjornsson S., Stefansson H., Sulem P., Gudbjartsson D., Maloney J., Hoyte K., Gustafson A., Liu Y., Lu Y., Bhangale T., Graham R.R., Huttenlocher J., Bjornsdottir G., Andreassen O.A., Jönsson E.G., Palotie A., Behrens T.W., Magnusson O.T., Kong A., Thorsteinsdottir U., Watts R.J., Stefansson K. Amutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488:96-99.
5. Prince, M., Jackson, J., World Alzheimer's report 2009 Executive summary. Alzheimer's Disease International. Available at: Accessed April 22,2013. http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf.
6. Stenh C., Nilsberth C., Hammarback J., Engvall B., Naslund J., Lannfelt L. The Arctic mutation interferes with processing of the amyloid precursor protein. Neuroreport 2002, 13:1857-1860.